Medicure Inc.
MCUJF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $8 | $7 | $5 | $6 |
| % Growth | 22.3% | 21.6% | -7% | – |
| Cost of Goods Sold | $5 | $3 | $3 | $2 |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 34% | 51.5% | 51.8% | 58.4% |
| R&D Expenses | $1 | $1 | $1 | $1 |
| G&A Expenses | $1 | $1 | $1 | $1 |
| SG&A Expenses | $3 | $3 | $3 | $3 |
| Sales & Mktg Exp. | $2 | $2 | $2 | $2 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $4 | $3 | $4 |
| Operating Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -16.1% | -10.5% | -11.9% | -8.5% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$1 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | -17.1% | -11.8% | -12.7% | -9.4% |
| EPS | -0.13 | -0.075 | -0.07 | -0.053 |
| % Growth | -72.6% | -7.6% | -32.1% | – |
| EPS Diluted | -0.13 | -0.08 | -0.07 | -0.053 |
| Weighted Avg Shares Out | 11 | 10 | 10 | 10 |
| Weighted Avg Shares Out Dil | 11 | 10 | 10 | 10 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$1 | -$0 | -$0 | $2 |
| % Margin | -8% | -0.9% | -0.1% | 35.6% |